Back to Search
Start Over
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms
- Source :
- Plus Company Updates. October 15, 2021
- Publication Year :
- 2021
-
Abstract
- LONDON: Frost & Sullivan has issued the following news release: Based on its recent analysis of the European AI-enabled drug discovery market, Frost & Sullivan recognizes Evaxion Biotech A/S (Evaxion) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.679160762